Keryx Biopharmaceuticals (KERX)
Keryx Biopharmaceuticals Revenue Growth
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
KERX Revenue Growth Range, Past 5 Years
| Minimum | -79.76% | Jun 2007 |
| Maximum | 4621% | Jun 2009 |
| Average | 948.3% |
About Revenue Growth
Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.
If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
Learn More
You may also be interested in these KERX related companies
KERX News
@HighRiskBuyer $KERX Gotta love this stock going into next week
about 14 hours ago by GucciMoccasins
about 14 hours ago by GucciMoccasins
Not a big chart guy but how can you not love $kerx going into next week?!?
about 14 hours ago by HighRiskBuyer
about 14 hours ago by HighRiskBuyer
@gregthor $KERX I think after good presentation big buyers should come in on Tuesday. Lets hope for huge volume and higher stock price!
about 18 hours ago by BiopharmaPro
about 18 hours ago by BiopharmaPro
$KERX big presentation tomorrow? hope it opens at 2.50 Tuesday. Have a great weekend everyone!!!!
about 18 hours ago by gregthor
about 18 hours ago by gregthor
$KERX anybody have thoughts on the insider trading going on w/ this name? Looks like mgmt has been buying up shares like mad since April
about 22 hours ago by HDINVEST
about 22 hours ago by HDINVEST
$KERX Are you selling-holding-buying going into Memorial day holiday? Markets will be closed May 28th
about a day ago by JasonMilano8
about a day ago by JasonMilano8
$KERX went back in today, I think it's well rested from the last run. Time to get moving again.
about a day ago by HighRiskBuyer
about a day ago by HighRiskBuyer
@SomeGuy900 $KERX I'm thinking after conference on Zerenex on Saturday , it may pop on Tuesday with big volume!!!
about 2 days ago by BiopharmaPro
about 2 days ago by BiopharmaPro
$KERX Does anybody know who went to Paris for Zerenex presentation at European Dialysis Congress (May 26th)?http://stks.co/3yhk
about 2 days ago by JasonMilano8
about 2 days ago by JasonMilano8
RT @JasonMilano8 $KERX, $AMRN, $SPPI sold and completely out until mid june. stock will be much cheaper in 2-3 weeks.LOL to early out
about 2 days ago by dkcba007
about 2 days ago by dkcba007
$KERX, $AMRN, $SPPI sold and completely out until mid june. stock will be much cheaper in 2-3 weeks.
about 2 days ago by JasonMilano8
about 2 days ago by JasonMilano8
$KERX Don't hate on my 7k shares. This is people's money don't post fake info please
about 3 days ago by newkidontheblock
about 3 days ago by newkidontheblock
$KERX presentation this Saturday for Zerenex at the ERA-EDTA. Memorial day is Monday im buying before Friday Lets hope the stock goes up : )
about 3 days ago by Sammyness
about 3 days ago by Sammyness
$KERX: Chart Analysis indicates counter trend rally is underway. The current up-trend could be changing and moving into Sidelines Mode.
about 3 days ago by nd4spd30
about 3 days ago by nd4spd30
BMC Software, The Ultimate Software Group Included in Stocks Up on High Volume Monday
May 14, 12:33PM Fox Business
May 14, 12:33PM Fox Business
Morning Movers 05/14: (GOLF) (VTUS) (KERX) Higher; (IOC) (ACOM) (ANIK) Lower
May 14, 10:07AM Street Insider
May 14, 10:07AM Street Insider
Unusual 11 Mid-Day Movers 05/11: (ARNA) (RPRX) (GWAY) Higher; (ADY) (AMOT) (ASYS) Lower
May 11, 1:56PM Street Insider
May 11, 1:56PM Street Insider
Unusual 11 Mid-Day Movers 05/10: (ADY) (INSP) (RPRX) Higher; (SGI) (WFR) (ARX) Lower
May 10, 2:24PM Street Insider
May 10, 2:24PM Street Insider
UPDATE: Ladenburg Thalmann Upgrades Keryx Biopharmaceuticals; Establishes PT
May 10, 10:54AM Benzinga
May 10, 10:54AM Benzinga
Keryx Biopharmaceuticals to Present at The 11th Annual JMP Securities Research Conference
May 10, 8:30AM PR Newswire
May 10, 8:30AM PR Newswire
Aeterna (AEZS), Keryx (KERX) Terminate Perifosine License Agreement in North America
May 07, 7:40AM Street Insider
May 07, 7:40AM Street Insider
Pharmaceutical Companies Look to Biotech Industry to Combat Losses From Expiring Patents
Apr 23, 8:20AM Marketwire
Apr 23, 8:20AM Marketwire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| KERX | 1.75 | +0.00 | +0.00% | 124.28M |
| KEP | 9.36 | -0.03 | -0.32% | 12.02B |
| KBW | 15.66 | +0.11 | +0.71% | 501.43M |
| KBALB | 6.89 | +0.05 | +0.73% | 261.13M |
| KALU | 49.46 | -0.41 | -0.82% | 952.10M |
| JRJC | 1.66 | +0.03 | +1.84% | 36.44M |
| JRCC | 3.10 | -0.10 | -3.12% | 111.44M |
| JQC | 9.16 | +0.04 | +0.44% | |
| JPM | 33.50 | -0.47 | -1.38% | 127.88B |
| JNPR | 17.15 | +0.15 | +0.88% | 9.027B |
